$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Effects of Atorvastatin 20 mg, Rosuvastatin 10 mg, and Atorvastatin/Ezetimibe 5 mg/5 mg on Lipoproteins and Glucose Metabolism

Journal of cardiovascular pharmacology and therapeutics, v.15 no.2, 2010년, pp.167 - 174  

Her, Ae-Young (Cardiology Division, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea) ,  Kim, Jong-Youn (Cardiology Division, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea) ,  Kang, Seok-Min (Cardiology Division, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea) ,  Choi, Donghoon (Cardiology Division, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea) ,  Jang, Yangsoo (Cardiology Division, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea) ,  Chung, Namsik (Cardiology Division, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea) ,  Manabe, Ichiro (Department of Cardiovascular Medicine and Nano-Bioengineering Education Program, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan) ,  Lee, Sang-Hak (Cardiology Division, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea,)

Abstract AI-Helper 아이콘AI-Helper

The aim of this study was to compare the effects of 3 different statin regimens that have equivalent low-density lipoprotein cholesterol (LDL-C) lowering efficacy on the apolipoprotein B/A1 ratio and glucose metabolism. After a 4-week dietary lead-in, 90 hypercholeserolemic patients were randomly a...

참고문헌 (36)

  1. Sager, Philip T., Capece, Rachel, Lipka, Leslie, Strony, John, Yang, Bo, Suresh, Ramachandran, Mitchel, Yale, Veltri, Enrico. Effects of ezetimibe coadministered with simvastatin on C-reactive protein in a large cohort of hypercholesterolemic patients. Atherosclerosis, vol.179, no.2, 361-367.

  2. Rizzo, Manfredi, Berneis, Kaspar. The Clinical Relevance of Low-Density-Lipoproteins Size Modulation by Statins. Cardiovascular drugs and therapy, vol.20, no.3, 205-217.

  3. Sasaki, Jun, Iwashita, Mikio, Kono, Suminori. Statins: Beneficial or Adverse for Glucose Metabolism. Journal of atherosclerosis and thrombosis, vol.13, no.3, 123-129.

  4. WOLFFENBUTTEL, B. H. R., FRANKEN, A. A. M., VINCENT, H. H.. Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes – CORALL study. Journal of internal medicine, vol.257, no.6, 531-539.

  5. Freeman, Dilys J., Norrie, John, Sattar, Naveed, Neely, R. Dermot G., Cobbe, Stuart M., Ford, Ian, Isles, Christopher, Lorimer, A. Ross, Macfarlane, Peter W., McKillop, James H., Packard, Christopher J., Shepherd, James, Gaw, Allan. Pravastatin and the Development of Diabetes Mellitus : Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study. Circulation, vol.103, no.3, 357-362.

  6. Ridker, Paul M, Danielson, Eleanor, Fonseca, Francisco A.H., Genest, Jacques, Gotto Jr., Antonio M., Kastelein, John J.P., Koenig, Wolfgang, Libby, Peter, Lorenzatti, Alberto J., MacFadyen, Jean G., Nordestgaard, Børge G., Shepherd, James, Willerson, James T., Glynn, Robert J.. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. The New England journal of medicine, vol.359, no.21, 2195-2207.

  7. Walldius, Göran, Jungner, Ingmar, Holme, Ingar, Aastveit, Are H, Kolar, Werner, Steiner, Eugen. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. The Lancet, vol.358, no.9298, 2026-2033.

  8. Benn, Marianne, Nordestgaard, Børge G., Jensen, Gorm Boje, Tybjærg-Hansen, Anne. Improving Prediction of Ischemic Cardiovascular Disease in the General Population Using Apolipoprotein B : The Copenhagen City Heart Study. Arteriosclerosis, thrombosis, and vascular biology, vol.27, no.3, 661-670.

  9. Feldman, Theodore, Koren, Michael, Insull Jr., William, McKenney Jr., James, Schrott Jr., Helmut, Lewin Jr., Andrew, Shah Jr., Sukrut, Sidisin Jr., Michelle, Cho Jr., Meehyung, Kush Jr., Debra, Mitchel Jr., Yale. Treatment of High-Risk patients with ezetimibe plus simvastatin Co-Administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III Low-Density lipoprotein cholesterol goals. The American journal of cardiology, vol.93, no.12, 1481-1486.

  10. Ballantyne, Christie M, Blazing, Michael A, King, Thomas R, Brady, William E, Palmisano, Joanne. Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia. The American journal of cardiology, vol.93, no.12, 1487-1494.

  11. Stein, Evan, Stender, Steen, Mata, Pedro, Sager, Philip, Ponsonnet, Damien, Melani, Lorenzo, Lipka, Leslie, Suresh, Ramachandran, MacCubbin, Darbie, Veltri, Enrico. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: Efficacy and safety of ezetimibe co-administered with atorvastatin. The American heart journal, vol.148, no.3, 447-455.

  12. Tremblay, André J., Lamarche, Benoît, Cohn, Jeffrey S., Hogue, Jean-Charles, Couture, Patrick. Effect of Ezetimibe on the In Vivo Kinetics of ApoB-48 and ApoB-100 in Men With Primary Hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology, vol.26, no.5, 1101-1106.

  13. Kalogirou, Mihalis, Tsimihodimos, Vasilis, Gazi, Irene, Filippatos, Theodosios, Saougos, Vasilis, Tselepis, Alexandros D., Mikhailidis, Dimitri P., Elisaf, Moses. Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemia. Current medical research and opinion : CMRO, vol.23, no.5, 1169-1176.

  14. Denke, Margo, Pearson, Thomas, McBride, Patrick, Gazzara, Russell A, Brady, William E, Tershakovec, Andrew M. Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome. Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease, vol.3, no.2, 93-102.

  15. Piorkowski, M., Fischer, S., Stellbaum, C., Jaster, M., Martus, P., Morguet, A.J., Schultheiss, H.P., Rauch, U.. Treatment With Ezetimibe Plus Low-Dose Atorvastatin Compared With Higher-Dose Atorvastatin Alone. Journal of the American College of Cardiology, vol.49, no.10, 1035-1042.

  16. Liu, Ping-Yen, Liu, Yen-Wen, Lin, Li-Jen, Chen, Jyh-Hong, Liao, James K.. Evidence for Statin Pleiotropy in Humans : Differential Effects of Statins and Ezetimibe on Rho-Associated Coiled-Coil Containing Protein Kinase Activity, Endothelial Function, and Inflammation. Circulation, vol.119, no.1, 131-138.

  17. Deedwania, Prakash C., Hunninghake, Donald B., Bays, Harold E., Jones, Peter H., Cain, Valerie A., Blasetto, James W.. Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome. The American journal of cardiology, vol.95, no.3, 360-366.

  18. Milionis, Haralampos J., Rizos, Evangelos, Kostapanos, Michael, Filippatos, Theodosios D., Gazi, Irene F., Ganotakis, Emmanuel S., Goudevenos, John, Mikhailidis, Dimitri P., Elisaf, Moses S.. Treating to target patients with primary hyperlipidaemia:comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study). Current medical research and opinion : CMRO, vol.22, no.6, 1123-1131.

  19. Am Heart J. Schwarz GG e4 148 1 2004 10.1016/S0002-8703(04)00376-X 

  20. Freeman, Dilys J., Norrie, John, Sattar, Naveed, Neely, R. Dermot G., Cobbe, Stuart M., Ford, Ian, Isles, Christopher, Lorimer, A. Ross, Macfarlane, Peter W., McKillop, James H., Packard, Christopher J., Shepherd, James, Gaw, Allan. Pravastatin and the Development of Diabetes Mellitus : Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study. Circulation, vol.103, no.3, 357-362.

  21. Lancet Hear Protection Study Collaborative Group. 360 9326 2002 

  22. Lancet Sever PS 1149 361 9364 2003 10.1016/S0140-6736(03)12948-0 

  23. Cannon, Christopher P., Braunwald, Eugene, McCabe, Carolyn H., Rader, Daniel J., Rouleau, Jean L., Belder, Rene, Joyal, Steven V., Hill, Karen A., Pfeffer, Marc A., Skene, Allan M.. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes. The New England journal of medicine, vol.350, no.15, 1495-1504.

  24. Huptas, Sebastian, Geiss, Hans-Christian, Otto, Carsten, Parhofer, Klaus Georg. Effect of Atorvastatin (10 mg/day) on Glucose Metabolism in Patients With the Metabolic Syndrome. The American journal of cardiology, vol.98, no.1, 66-69.

  25. Tanaka, Akira, Yamada, Nobuhiro, Saito, Yasushi, Kawakami, Masanobu, Ohashi, Yasuo, Akanuma, Yasuo. A double-blind trial on the effects of atorvastatin on glycemic control in Japanese diabetic patients with hypercholesterolemia. Clinica chimica acta, vol.312, no.1, 41-47.

  26. Takano, Tatsuro, Yamakawa, Tadashi, Takahashi, Mayumi, Kimura, Mari, Okamura, Atsushi. Influences of Statins on Glucose Tolerance in Patients with Type 2 Diabetes Mellitus. Journal of atherosclerosis and thrombosis, vol.13, no.2, 95-100.

  27. Clin Ther Sasaki J. 1089 30 6 2008 10.1016/j.clinthera.2008.05.017 

  28. Yada, Toshihiko, Nakata, Masanori, Shiraishi, Tomoko, Kakei, Masafumi. Inhibition by simvastatin, but not pravastatin, of glucose‐induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L‐type Ca2+ channels in rat islet β‐cells. British journal of pharmacology : BJP, vol.126, no.5, 1205-1213.

  29. Ishikawa, Mayumi, Okajima, Fuminori, Inoue, Noriyuki, Motomura, Kaori, Kato, Toyonori, Takahashi, Akimitsu, Oikawa, Shinichi, Yamada, Nobuhiro, Shimano, Hitoshi. Distinct Effects of Pravastatin, Atorvastatin, and Simvastatin on Insulin Secretion from a β-cell Line, MIN6 Cells. Journal of atherosclerosis and thrombosis, vol.13, no.6, 329-335.

  30. Nakata, M., Nagasaka, S., Kusaka, I., Matsuoka, H., Ishibashi, S., Yada, T.. Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control. Diabetologia, vol.49, no.8, 1881-1892.

  31. Dagli, Necati, Yavuzkir, Mustafa, Karaca, Ilgin. The Effects of High Dose Pravastatin and Low Dose Pravastatin and Ezetimibe Combination Therapy on Lipid, Glucose Metabolism and Inflammation. Inflammation, vol.30, no.6, 230-235.

  32. Naples, M., Federico, L.M., Xu, E., Nelken, J., Adeli, K.. Effect of rosuvastatin on insulin sensitivity in an animal model of insulin resistance: Evidence for statin-induced hepatic insulin sensitization. Atherosclerosis, vol.198, no.1, 94-103.

  33. Kostapanos, M. S., Milionis, H. J., Agouridis, A.-D., Rizos, C. V., Elisaf, M. S.. Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose. International journal of clinical practice, vol.63, no.9, 1308-1313.

  34. Clearfield, Michael B, Amerena, John, Bassand, Jean-Pierre, García, Hugo R Hernández, Miller, Sam S, Sosef, Froukje FM, Palmer, Michael K, Bryzinski, Brian S. Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR). Trials, vol.7, 35-35.

  35. Am J Manag Care Baruch L. 637 14 10 2008 

  36. Kosoglou, Teddy, Statkevich, Paul, Meyer, Ingo, Cutler, David L., Musiol, Bernhard, Yang, Bo, Zhu, Yali, Maxwell, Stephen E., Veltri, Enrico P.. Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatin. Current medical research and opinion : CMRO, vol.20, no.6, 955-965.

LOADING...
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로